161 related articles for article (PubMed ID: 24886197)
1. Vincristine-induced vocal cord palsy and successful re-treatment in a patient with diffuse large B cell lymphoma: a case report.
Samoon Z; Shabbir-Moosajee M
BMC Res Notes; 2014 May; 7():318. PubMed ID: 24886197
[TBL] [Abstract][Full Text] [Related]
2. Low-dose vincristine-associated bilateral vocal cord paralysis.
Ryan SP; DelPrete SA; Weinstein PW; Erichson RB; Bar MH; Lo KM; Cohen NS; Tepler I
Conn Med; 1999 Oct; 63(10):583-4. PubMed ID: 10578547
[TBL] [Abstract][Full Text] [Related]
3. Vocal cord paralysis during the treatment of mantle cell lymphoma with vincristine.
Yalin SF; Trabulus S; Yalin AS; Yalin GY; Ongoren S; Altiparmak MR
Int J Clin Pharm; 2013 Jun; 35(3):306-8. PubMed ID: 23338712
[TBL] [Abstract][Full Text] [Related]
4. Vincristine-induced recurrent laryngeal nerve paralysis.
Annino DJ; MacArthur CJ; Friedman EM
Laryngoscope; 1992 Nov; 102(11):1260-2. PubMed ID: 1405987
[TBL] [Abstract][Full Text] [Related]
5. Bilateral vocal cord paralysis following treatment with vincristine.
Naithani R; Dolai TK; Kumar R
Indian Pediatr; 2009 Jan; 46(1):68-9. PubMed ID: 19179723
[TBL] [Abstract][Full Text] [Related]
6. Vincristine-Induced Bilateral Vocal Cord Palsy in an Adult Male With Diffuse Large B-Cell Lymphoma.
Leedman S; Flukes S
Cureus; 2021 Oct; 13(10):e18591. PubMed ID: 34765356
[TBL] [Abstract][Full Text] [Related]
7. [Vocal cord paralysis secondary to vincristine].
Nafil H; Tazi I; Mahmal L
Rev Neurol (Paris); 2012 May; 168(5):464-5. PubMed ID: 22387202
[No Abstract] [Full Text] [Related]
8. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
[TBL] [Abstract][Full Text] [Related]
9. Vincristine-induced vocal cord paralysis in an infant.
Anghelescu DL; De Armendi AJ; Thompson JW; Sillos EM; Pui CH; Sandlund JT
Paediatr Anaesth; 2002 Feb; 12(2):168-70. PubMed ID: 11882230
[TBL] [Abstract][Full Text] [Related]
10. Vincristine-induced vocal cord palsy: case report and review of the literature.
Latiff ZA; Kamal NA; Jahendran J; Alias H; Goh BS; Syed Zakaria SZ; Jamal R
J Pediatr Hematol Oncol; 2010 Jul; 32(5):407-10. PubMed ID: 20505534
[TBL] [Abstract][Full Text] [Related]
11. Vincristine-induced seizure potentiated by itraconazole following RCHOP chemotherapy for diffuse large B-cell lymphoma.
Foroughinia F; Baniasadi S; Seifi S; Fahimi F
Curr Drug Saf; 2012 Nov; 7(5):372-4. PubMed ID: 23320431
[TBL] [Abstract][Full Text] [Related]
12. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
13. Vincristine-induced vocal cord paresis and paralysis in children.
Zavala H; Roby BB; Day A; Bostrom B; Sidman J; Chinnadurai S
Int J Pediatr Otorhinolaryngol; 2019 Aug; 123():1-4. PubMed ID: 31048222
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Oncology Patients With Vincristine-Induced Recurrent Laryngeal Nerve Palsy: Two Case Reports and a Brief Review of Literature.
Tay SY; Foster J; Heczey A; Sitton M
Ear Nose Throat J; 2021 Dec; 100(10):NP459-NP463. PubMed ID: 32425060
[TBL] [Abstract][Full Text] [Related]
15. Low-dose vincristine-associated bilateral vocal cord paralysis.
Alfredsunder P; Hochman MC; Kaplan BH
N Y State J Med; 1992 Jun; 92(6):268-9. PubMed ID: 1641212
[No Abstract] [Full Text] [Related]
16. 3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis.
Araie H; Sakamaki I; Matsuda Y; Tai K; Ikegaya S; Itoh K; Kishi S; Oiwa K; Okura M; Tasaki T; Hosono N; Ueda T; Yamauchi T
Intern Med; 2017 Sep; 56(18):2407-2413. PubMed ID: 28824057
[TBL] [Abstract][Full Text] [Related]
17. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y
Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202
[TBL] [Abstract][Full Text] [Related]
18. A case of primary adrenal diffuse large B-cell lymphoma achieving complete remission with rituximab-CHOP chemotherapy.
Kim KM; Yoon DH; Lee SG; Lim SN; Sug LJ; Huh J; Suh C
J Korean Med Sci; 2009 Jun; 24(3):525-8. PubMed ID: 19543522
[TBL] [Abstract][Full Text] [Related]
19. Vocal fold palsy following vinca alkaloid treatment.
Burns BV; Shotton JC
J Laryngol Otol; 1998 May; 112(5):485-7. PubMed ID: 9747483
[TBL] [Abstract][Full Text] [Related]
20. [A case of neurotoxicity reduced with pregabalin in R-CHOP chemotherapy for diffuse large B-cell lymphoma].
Nakashima T; Kiba T; Ogawa Y; Kimura A; Kido M; Okikawa Y; Ito T; Saito A; Hosokawa A; Shintani H; Okada Y; Taniguchi T; Taniyama K; Kozawa K; Niimi H
Gan To Kagaku Ryoho; 2012 May; 39(5):809-12. PubMed ID: 22584337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
